Coadministration of rapamycin with a DNA/MVA SIV vaccine improves memory CD8+ T cell response
JCI Insight · 08.06.2026 · 11 (11)
DOI: 10.1172/jci.insight.193752 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 23.04.2026. Verfasst von Shanmugalakshmi Sadagopal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Emory Vaccine Center, Emory National Primate Research Center, and. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Sirolimus, SAIDS Vaccines, Vaccines, DNA. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NIAID, Emory National Primate Research Center base grant, Emory CFAR grant.
Abstract (Originalsprache)
Inhibiting the mammalian target of rapamycin (mTOR) during acute viral infection generates highly functional memory CD8 + T cells. We investigated the effects of inhibiting mTOR by using rapamycin during the effector and contraction phases of the immune response to a DNA prime and Modified Vaccinia Ankara (MVA) boost SIV vaccination in rhesus macaques. Rapamycin administered either during MVA boosts alone (DM R ) or during both primes and boosts (D R M R ) reduced the contraction of effector CD8 + T cells, resulting in higher frequencies of SIV-specific memory CD8 + T cells with enhanced quality, as indicated by expression of Bcl2 and CD127. Additionally, rapamycin reduced the frequency of proliferating CCR5 + CD4 + T cells in the blood following the MVA boost. After SIVmac251 infection, rapamycin-treated macaques demonstrated marked expansion of SIV-specific CD8 + T cells (reaching up to 50% in blood and 25% in gut). The heightened expansion of SIV-specific CD8 + T cells in the DM R group was associated with markedly lower (2-logs compared with unvaccinated and 1-log compared with DM) peak viral load in the gut and set-point viremia, along with improved survival after infection. Thus, inhibiting the mTOR pathway during MVA boosts of a DNA/MVA vaccine enhances vaccine efficacy by improving memory CD4 + and CD8 + T cell function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emory Vaccine Center, Emory National Primate Research Center, and.
- Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
Förderung
- NIH/NIAID
- Emory National Primate Research Center base grant
- Emory CFAR grant
- Office of Research Infrastructure Programs
Zitieren
APA
Sadagopal, S., Stokdyk, K., Kwa, S., Basu, R., Gangadhara, S., Ahmed, R., Iyer, S. S., Araki, K., & Amara, R. R. (2026). Coadministration of rapamycin with a DNA/MVA SIV vaccine improves memory CD8+ T cell response. JCI Insight, 11(11). https://doi.org/10.1172/jci.insight.193752
Vancouver
Sadagopal S, Stokdyk K, Kwa S, Basu R, Gangadhara S, Ahmed R, et al. Coadministration of rapamycin with a DNA/MVA SIV vaccine improves memory CD8+ T cell response. JCI Insight. 2026;11(11). doi:10.1172/jci.insight.193752
BibTeX
@article{Sadagopal2026,
author = {Sadagopal, Shanmugalakshmi and Stokdyk, Kasey and Kwa, Suefen and Basu, Rahul and Gangadhara, Sailaja and Ahmed, Rafi and Iyer, Smita S and Araki, Koichi and Amara, Rama Rao},
title = {Coadministration of rapamycin with a DNA/MVA SIV vaccine improves memory CD8+ T cell response},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {11},
doi = {10.1172/jci.insight.193752}
}
EUVIMED